IL-17, known for driving inflammation, also puts on the brakes, NIH scientists report NIH/NATIONAL EYE INSTITUTE AFTER ACTIVATION THROUGH ITS T-CELL RECEPTOR, TH17 CELLS PRODUCE IL-17A, WHICH BINDS TO ITS OWN RECEPTOR ON THE TH17 CELL. THIS ACTIVATES THE NFΚB PATHWAY. NFΚB DRIVES PRODUCTION OF IL-24,… view more CREDIT: RACHEL CASPI, PH.D. (NEI) The inflammatory...